FOR IMMEDIATE RELEASE
MESA, Ariz. — December 12, 2024
Dr. Marchand’s new paper “Efficacy of conservative laparoscopic surgical treatment for acute ovarian torsion in pediatrics and adolescent populations: A single-armed meta-analysis” is now available online! You can view this exciting analysis on the original journal website here:
Or on the NIH’s Pubmed Website here:
https://pubmed.ncbi.nlm.nih.gov/39663806/
Dr. Marchand and the Marchand Institute look forward to your feedback on our latest work!
About Dr. Greg Marchand
Greg J. Marchand, MD, FACS, FACOG, FICS, is a dual board-certified obstetrician-gynecologist and minimally invasive gynecologic surgeon practising in Mesa, Arizona. He holds the ABOG Focused Practice Designation in Minimally Invasive Gynecologic Surgery and directs the Marchand Institute for Minimally Invasive Surgery, a 501(c)(3) tax-exempt non-profit research and educational corporation (EIN 42-2857240). He is Program Director of an SLS-accredited fellowship in Minimally Invasive and Robotic Gynecologic Surgery, holds three issued United States patents, and has served as Principal Investigator on eight FDA clinical trials. His systematic reviews are prospectively registered with PROSPERO, reported to PRISMA standards and appraised with the Cochrane Risk of Bias 2 tool. He accepts no industry funding for his research.
Media Contact
Maria A. Sainz
Director of Communications and Media Relations
maria@marchandobgyn.com
(480) 999-0905
Newsroom and press kit · Full publication list · Research methodology · Expert commentary topics
###







